These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 7992018

  • 1. Prevalence of HBeAg and HBsAg seroconversion in patients with chronic hepatitis B.
    Stránský J, Chlumská A, Zichová M, Helm R, Mankovecký L, König J.
    Sb Lek; 1993; 94(4):317-25. PubMed ID: 7992018
    [Abstract] [Full Text] [Related]

  • 2. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
    Chlumská A, Stránský J, Taimr P, Baumruk L, Nevaril M.
    Vnitr Lek; 1995 Jul; 41(7):445-8. PubMed ID: 7571477
    [Abstract] [Full Text] [Related]

  • 3. Preference and significance of HBeAg and anti-HBe, determined by enzyme immunoassay, in patients with acute, chronic and resolved hepatitis B.
    Niermeijer P, Gips CH, Huizenga JR, van der Waart M, Schuurs A.
    Hepatogastroenterology; 1980 Oct; 27(5):350-5. PubMed ID: 7203369
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of lamivudine-induced HBsAg loss rate according to age in children with chronic hepatitis B].
    Kim JM, Choe BH, Chu MA, Cho SM.
    Korean J Hepatol; 2009 Jun; 15(2):168-78. PubMed ID: 19581769
    [Abstract] [Full Text] [Related]

  • 5. Clinical importance of assessment of HBsAg/IgM complexes in chronic hepatitis B.
    Stránský J, Vodák M, Zichová M.
    Acta Virol; 1993 Jun; 37(2-3):170-4. PubMed ID: 8105661
    [Abstract] [Full Text] [Related]

  • 6. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A, Sekiya C, Yazaki Y, Tominaga Y, Oohara K, Ono M, Sato H, Hasebe C, Namiki M.
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [Abstract] [Full Text] [Related]

  • 7. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K, Değertekin H, Kokoğlu OF, Ayaz C.
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers.
    Kao JH, Chen PJ, Lai MY, Chen DS.
    J Med Virol; 2004 Mar; 72(3):363-9. PubMed ID: 14748059
    [Abstract] [Full Text] [Related]

  • 9. Seroconversion of HBsAg in HBeAg positive and HBeAg negative patients with chronic HBV treated with entecavir: a case series.
    d'Ettorre G, Barbarini G, Corti F, Gobber M, Pastecchia C, Ricci GL, Siciliano M, Annicchiarico BE, Vullo V.
    Eur Rev Med Pharmacol Sci; 2010 Jun; 14(6):551-4. PubMed ID: 20712263
    [Abstract] [Full Text] [Related]

  • 10. Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma.
    Chen DS, Sung JL, Lai MY.
    Hepatogastroenterology; 1981 Dec; 28(6):288-91. PubMed ID: 6284625
    [Abstract] [Full Text] [Related]

  • 11. [Mid-term natural course in Naples of chronic HBeAg positive infection caused by the HB-virus. Prospective study, preliminary to antiviral treatment].
    Canestrini C, Amitrano L, Ascione A, De Lella A, De Luca M, Ferbo U, Riccio E, Gigliotti T.
    Minerva Dietol Gastroenterol; 1989 Dec; 35(2):119-22. PubMed ID: 2761751
    [Abstract] [Full Text] [Related]

  • 12. Investigations on HBe antigen. Note II. Dynamics of HBsAg in acute viral hepatitis, according to HBeAg persistence or seroconversion.
    Babeş VT, Cepănaru S, Cepănaru R, Tănase M.
    Virologie; 1981 Dec; 32(3):187-91. PubMed ID: 7303492
    [Abstract] [Full Text] [Related]

  • 13. The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age.
    Chang MH, Hsu HY, Hsu HC, Ni YH, Chen JS, Chen DS.
    Hepatology; 1995 Nov; 22(5):1387-92. PubMed ID: 7590652
    [Abstract] [Full Text] [Related]

  • 14. [Clinico-prognostic significance of partial seroconversion in chronic viral hepatitis B follow-up. Wartenbert Study (1974-1994), II].
    Ohlen I, Liegl JM, Selmair H.
    Leber Magen Darm; 1995 Dec; 25(6):259-62. PubMed ID: 8577215
    [Abstract] [Full Text] [Related]

  • 15. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
    Bujanda L, García Bengoechea M, Cilla G, Gil I, yArenas JI.
    Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
    [Abstract] [Full Text] [Related]

  • 16. [Durability of HBeAg seroconversion in lamivudine treatment of chronic hepatitis B patients].
    Zhu M, Xu B, Yao GB.
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):534-6. PubMed ID: 16042894
    [Abstract] [Full Text] [Related]

  • 17. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels.
    Chu CM, Hung SJ, Lin J, Tai DI, Liaw YF.
    Am J Med; 2004 Jun 15; 116(12):829-34. PubMed ID: 15178498
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B.
    Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, Liaw YF.
    Hepatology; 2002 Jun 15; 35(6):1522-7. PubMed ID: 12029639
    [Abstract] [Full Text] [Related]

  • 19. Clearance of hepatitis B surface antigen after bone marrow transplantation: role of adoptive immunity transfer.
    Lau GK, Lok AS, Liang RH, Lai CL, Chiu EK, Lau YL, Lam SK.
    Hepatology; 1997 Jun 15; 25(6):1497-501. PubMed ID: 9185774
    [Abstract] [Full Text] [Related]

  • 20. [Anti-HBs-F(ab)'2 to the seroconversion of HBsAg carriers].
    An P.
    Zhonghua Yi Xue Za Zhi; 1992 Nov 15; 72(11):647-50, 701. PubMed ID: 1338699
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.